Asociaciones

  1. Portada
  2. Investigación
  3. Publicaciones
  4. Grupo de Investigación en Innovación, terapia y desarrollo farmacéutico en oftalmología. Universidad Complutense de Madrid

Grupo de Investigación en Innovación, terapia y desarrollo farmacéutico en oftalmología. Universidad Complutense de Madrid

  1. Co-delivery of glial cell-derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases.

Arranz-Romera A, Esteban-Pérez S, Molina-Martínez IT, Bravo-Osuna I, Herrero-Vanrell R.Drug Deliv Transl Res. 2021 Apr;11(2):566-580. doi: 10.1007/s13346-021-00930-9. Epub 2021 Feb 27.PMID: 33641047

  1. Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration.

Garcia-Herranz D, Rodrigo MJ, Subias M, Martinez-Rincon T, Mendez-Martinez S, Bravo-Osuna I, Bonet A, Ruberte J, Garcia-Feijoo J, Pablo L, Garcia-Martin E, Herrero-Vanrell R.Pharmaceutics. 2021 Feb 8;13(2):237. doi: 10.3390/pharmaceutics13020237.PMID: 33567776 

  1. Thermo-Responsive PLGA-PEG-PLGA Hydrogels as Novel Injectable Platforms for Neuroprotective Combined Therapies in the Treatment of Retinal Degenerative Diseases.

López-Cano JJ, Sigen A, Andrés-Guerrero V, Tai H, Bravo-Osuna I, Molina-Martínez IT, Wang W, Herrero-Vanrell R.Pharmaceutics. 2021 Feb 7;13(2):234. doi: 10.3390/pharmaceutics13020234.PMID: 33562265

  1. Dexamethasone PLGA Microspheres for Sub-Tenon Administration: Influence of Sterilization and Tolerance Studies.

Barbosa-Alfaro D, Andrés-Guerrero V, Fernandez-Bueno I, García-Gutiérrez MT, Gil-Alegre E, Molina-Martínez IT, Pastor-Jimeno JC, Herrero-Vanrell R, Bravo-Osuna I.Pharmaceutics. 2021 Feb 6;13(2):228. doi: 10.3390/pharmaceutics13020228.PMID: 33562155 

  1. A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies.

Arranz-Romera A, Hernandez M, Checa-Casalengua P, Garcia-Layana A, Molina-Martinez IT, Recalde S, Young MJ, Tucker BA, Herrero-Vanrell R, Fernandez-Robredo P, Bravo-Osuna I.Pharmaceuticals (Basel). 2021 Jan 11;14(1):50. doi: 10.3390/ph14010050.PMID: 33440745

  1. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.

López-Cano JJ, González-Cela-Casamayor MA, Andrés-Guerrero V, Herrero-Vanrell R, Molina-Martínez IT.Expert Opin Drug Deliv. 2021 Jan 22:1-29. doi: 10.1080/17425247.2021.1872542. Online ahead of print.PMID: 33412914